Pharmaceutical Technologies

The following section deals with manufacturing technologies of Pharmaceuticals and up-to-date pharmaceutical equipment


Avalon GloboCare formed Avactis Biosciences to develop CAR-T therapies

Avalon GloboCare (USA), a leading global developer of cell-based technologies and therapeutics, formed a new wholly owned. subsidiary, Avactis Biosciences.
lab research

Sobi gained global rights for emapalumab from Novimmune

Swedish Orphan Biovitrum AB and Novimmune SA have entered into an licence agreement for the global rights to an orphan drug candidate for the treatment of primary Haemophagocytic lymphohistiocytosis (HLH).
lab plates

Kite will collaborate with Gadeta on gamma delta TCR therapies

Kite, a Gilead Company, and Gadeta B.V have entered into a strategic collaboration to develop novel gamma delta TCR therapies in various cancers.

Innovest Global launches its Biotech and Health Services division

Innovest Global launched its anticipated Biotechnology & Health Services Division with the acquisition of a twenty percent interest in StemVax Therapeutics.

Taconic Biosciences and Cyagen Biosciences enter into strategic partnership

Taconic Biosciences and Cyagen Biosciences, global leaders in the generation of custom genetically engineered rodent models and associated services, announced a strategic partnership.
good laboratory practice

Sinovant Sciences unveiled its drug pipeline

Sinovant Sciences, a Shanghai-based biopharmaceutical company dedicated to bringing innovative medicines to China and advancing Chinese biopharmaceutical innovation abroad, unveiled its pipeline and leadership team.

Novartis buys exclusive rights to a promising dermatologic drug

Novartis announced that it has entered into an exclusive license agreement with biotech companies Galapagos NV, Mechelen (Belgium) and MorphoSys AG, Planegg/Munich (Germany) regarding their compound MOR106.

Hong Kong Polytechnic University and Axis create a Joint Center for Immunotherapy

The Hong Kong Polytechnic University will join forces with Axis Therapeutics, a newly established joint venture by Athenex, Inc. and Xiangxue Pharmaceutical.


Expert opinion